Fresenius SE - 15 Year Stock Price History | FSNUY
Historical daily share price chart and data for Fresenius SE since 2011 adjusted for splits and dividends. The latest closing stock price for Fresenius SE as of September 15, 2026 is 13.13.
- The all-time high Fresenius SE stock closing price was 21.83 on October 31, 2025.
- The Fresenius SE 52-week high stock price is 33.93, which is 158.4% above the current share price.
- The Fresenius SE 52-week low stock price is 10.33, which is 21.3% below the current share price.
- The average Fresenius SE stock price for the last 52 weeks is 13.41.
| Fresenius SE Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 12.7402 | 13.5947 | 14.9756 | 10.4000 | 13.1300 | -5.78% |
| 2025 | 11.9977 | 8.1891 | 21.8313 | 8.1891 | 13.9351 | 67.64% |
| 2024 | 7.7165 | 7.4766 | 9.1296 | 6.2986 | 8.3126 | 13.27% |
| 2023 | 6.8271 | 6.5590 | 7.8566 | 5.6863 | 7.3388 | 14.29% |
| 2022 | 6.9733 | 8.9574 | 9.7262 | 4.4461 | 6.4212 | -28.03% |
| 2021 | 10.5946 | 10.3057 | 12.8013 | 8.3942 | 8.9216 | -12.69% |
| 2020 | 9.9982 | 12.0506 | 12.0506 | 5.9716 | 10.2180 | -14.81% |
| 2019 | 11.1788 | 10.3783 | 12.4742 | 9.5288 | 11.9948 | 16.81% |
| 2018 | 15.6258 | 16.2520 | 18.3494 | 9.3430 | 10.2684 | -36.75% |
| 2017 | 17.0202 | 15.9052 | 18.6167 | 14.9987 | 16.2353 | 0.50% |
| 2016 | 14.9734 | 14.0926 | 16.9169 | 12.3166 | 16.1540 | 10.07% |
| 2015 | 13.2674 | 10.4102 | 15.3588 | 10.2903 | 14.6763 | 38.72% |
| 2014 | 10.3203 | 10.2179 | 11.2365 | 9.5684 | 10.5799 | 1.69% |
| 2013 | 8.4491 | 7.6499 | 10.4330 | 7.2246 | 10.4040 | 35.91% |
| 2012 | 7.1857 | 6.3394 | 8.2718 | 5.9593 | 7.6552 | 25.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $29.581B | $25.873B |
| Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |